Parithera
Providing a minimally invasive diagnostic which analyses cancer treatment resistance and allows clinicians to adjust treatment regimen.
Launch date
Employees
Epalinges Canton of Vaud (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
| N/A | CHF100k | Grant | |
N/A | Seed | ||
* | CHF100k | Debt | |
* | CHF90.0k | Grant | |
| Total Funding | €158k | ||
Recent News about Parithera
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.